Keyphrases
Duchenne muscular Dystrophy
85%
Myopathy
78%
Amyotrophic Lateral Sclerosis
77%
Acetylcholine Receptor (AChR)
61%
Autoantibodies
47%
Skeletal muscle
45%
Myasthenia Gravis
43%
Polyneuropathy
42%
Muscle Fiber
37%
Serum IgM
37%
Placebo
33%
Prednisone
33%
GM1 Ganglioside
32%
Dysferlinopathy
32%
Muscle Biopsy
27%
Clinical Features
26%
High Titer
26%
Multifocal Motor Neuropathy
25%
Idiopathic Inflammatory Myopathies
24%
Neuromuscular Junction
23%
Denervation
23%
Serum Antibody
22%
Axon
21%
Nerve
20%
Frontotemporal Dementia
19%
Demyelinating Polyneuropathy
19%
Inclusion Body Myopathy
19%
Lower Motor Neuron Syndrome
19%
Pompe Disease
18%
Motor Neuropathy
18%
Peripheral Nerve
17%
Muscle Strength
17%
Neuropathy
17%
Disease Progression
17%
Phase II Trial
16%
Cyclophosphamide
16%
IBMPFD
16%
Clinical Trials
16%
Clinical Correlation
15%
Antibody-associated
15%
Coenzyme Q10
15%
Dystrophin
14%
Anti-GM1 Antibodies
14%
Chronic Inflammatory Demyelinating Polyneuropathy
14%
Alglucosidase Alfa
14%
Muscle Pathology
14%
Paget's Disease of Bone
14%
Small Fiber Neuropathy
13%
Muscular Dystrophy
13%
Dermatomyositis
13%
Neuroscience
Muscle Disorder
100%
Neuropathy
79%
Polyneuropathy
54%
Immunoglobulin M
54%
Muscular Dystrophy
53%
Cholinergic Receptor
49%
Amyotrophic Lateral Sclerosis
49%
Autoantibodies
38%
Axon
34%
Skeletal Muscle
32%
Myasthenia gravis
31%
Denervation
20%
Myositis
19%
Peripheral Nerve
18%
Neuromuscular Junction
17%
Placebo
16%
Ganglioside GM1
15%
Myelin Associated Glycoprotein
14%
Lower Motor Neuron
13%
Prednisone
12%
Creatine Kinase
12%
Sulfatide
12%
Frontotemporal Dementia
12%
Disaccharide
12%
Magnetic Resonance Imaging
11%
Staining Technique
11%
Immunoglobulin M Antibody
11%
Electrodiagnosis
11%
Receptor
10%
Immunotherapy
10%
Exon
10%
Clostridium Botulinum Type A
9%
Coenzyme
8%
Heparin
8%
Cyclophosphamide
8%
Immunosuppression
8%
Immunosuppressive Drug
8%
Nerve Block
8%
Neuromuscular Disorder
8%
Ophthalmoparesis
8%
Intravenous Immunoglobulin
8%
Polymyositis
7%
Tubulin
7%
Motor Neuron Disease
7%
Bungarotoxin
7%
Rituximab
7%
Neuromuscular
7%
Receptor Antibody
7%
Ataxia
7%
Mitochondrial DNA
6%
Medicine and Dentistry
Myopathy
56%
Weakness
42%
Skeletal Muscle
31%
Disease
31%
Immunoglobulin M
26%
Duchenne Muscular Dystrophy
22%
Muscle Biopsy
22%
Dysferlinopathy
22%
Immunity
21%
Neuropathy
20%
Placebo
20%
Polyneuropathy
17%
Cholinergic Receptor
17%
Magnetic Resonance Imaging
16%
Denervation
16%
Multifocal Motor Neuropathy
15%
Amyotrophic Lateral Sclerosis
15%
Muscle Disease
14%
Immunosuppressive Treatment
13%
Axon
13%
Creatine Kinase
12%
Glycogen Storage Disease Type II
12%
Small Fiber Neuropathy
11%
Connective Tissue
11%
Limb
11%
Nerve Block
11%
Muscle Weakness
10%
Prednisone
10%
Ophthalmoparesis
10%
Electrodiagnosis
10%
Vacuolization
10%
Autoantibodies
10%
Clinical Trial
9%
Muscle Strength
9%
Disaccharide
9%
Demyelinating Neuropathy
9%
Adverse Event
9%
Disease Exacerbation
9%
Myositis
9%
Upper Limb
9%
Muscular Dystrophy
8%
Quality of Life
8%
Glucocorticoid
8%
Alglucosidase Alfa
8%
Oxidoreductase
8%
Plasma Exchange
8%
Clinical Feature
8%
Dermatomyositis
8%
Neuromuscular Junction
8%
Perimysium
8%